Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hikaru Sasaki

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[MGMT methylation]Hikaru Sasaki
The Lancet. Oncology|May 17, 2021
Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytomaHikaru Sasaki
No Shinkei Geka. Neurological Surgery|September 24, 2023
[Meningioma]Hikaru Sasaki
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities]Ryotaro Imai, Hikaru Sasaki
No Shinkei Geka. Neurological Surgery|March 12, 2016
[Molecular Classification and Personalized Treatment of Gliomas]Hikaru Sasaki, Kazunari Yoshida
Neural Networks : the Official Journal of the International Neural Network Society|June 24, 2021
Variational policy search using sparse Gaussian process priors for learning multimodal optimal actionsHikaru Sasaki, Takamitsu Matsubara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[II. Treatment of Glioblastoma with Alternating Electric Fields]Dai Kamamoto, Hikaru Sasaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Inhibition of cellular adhesion and invasion in gliomas]Hikaru Sasaki, Kazunari Yoshida
Neurologia Medico-Chirurgica|August 29, 2017
Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016Hikaru Sasaki, Kazunari Yoshida
No Shinkei Geka. Neurological Surgery|August 11, 2016
[Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective]Takashi Komori, Hikaru Sasaki, Kazunari Yoshida
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 13, 2019
[MGMT methylation]Hikaru Sasaki
The Lancet. Oncology|May 17, 2021
Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytomaHikaru Sasaki
No Shinkei Geka. Neurological Surgery|September 24, 2023
[Meningioma]Hikaru Sasaki
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities]Ryotaro Imai, Hikaru Sasaki
No Shinkei Geka. Neurological Surgery|March 12, 2016
[Molecular Classification and Personalized Treatment of Gliomas]Hikaru Sasaki, Kazunari Yoshida
Neural Networks : the Official Journal of the International Neural Network Society|June 24, 2021
Variational policy search using sparse Gaussian process priors for learning multimodal optimal actionsHikaru Sasaki, Takamitsu Matsubara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[II. Treatment of Glioblastoma with Alternating Electric Fields]Dai Kamamoto, Hikaru Sasaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 6, 2005
[Inhibition of cellular adhesion and invasion in gliomas]Hikaru Sasaki, Kazunari Yoshida
Neurologia Medico-Chirurgica|August 29, 2017
Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016Hikaru Sasaki, Kazunari Yoshida
No Shinkei Geka. Neurological Surgery|August 11, 2016
[Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective]Takashi Komori, Hikaru Sasaki, Kazunari Yoshida
Pageof 12